Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 10, 2026 21:28 UTC |
Gardner Christopher PDirector
|
GrantOrdinary Shares | 11,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-087358 · ownership.xml · nonDerivative · entry 1 Gardner Christopher P · CIK 0001776758 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,111 F1 · shares: These shares represent restricted share units and will be settled in ordinary shares upon vesting. F1 · balance_after: These shares represent restricted share units and will be settled in ordinary shares upon vesting. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:29 UTC |
Sutin Bleiberg Tania EsterDirector
|
GrantOrdinary Shares | 11,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-087362 · ownership.xml · nonDerivative · entry 1 Sutin Bleiberg Tania Ester · CIK 0002140555 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,111 F1 · shares: These shares represent restricted share units and will be settled in ordinary shares upon vesting. F1 · balance_after: These shares represent restricted share units and will be settled in ordinary shares upon vesting. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:29 UTC |
Ingrassia Richard AlanDirector
|
GrantOrdinary Shares | 11,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-087360 · ownership.xml · nonDerivative · entry 1 Ingrassia Richard Alan · CIK 0002140554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,111 F1 · shares: These shares represent restricted share units and will be settled in ordinary shares upon vesting. F1 · balance_after: These shares represent restricted share units and will be settled in ordinary shares upon vesting. Read SEC document |
| August 10, 2026 Filed Aug 10, 2026 21:28 UTC |
Jadue Musalem Joaquin NicolasChief Financial Officer
|
GrantOrdinary Shares | 153,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-087359 · ownership.xml · nonDerivative · entry 1 Jadue Musalem Joaquin Nicolas · CIK 0002103559 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · By Medistat SpA Disclosed balance after: 153,846 F1 · ownership.nature: The reporting person is the general manager of Medistat SpA and has sole voting and dispositive power over the shares held by Medistat SpA. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.